Perrault syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2855OMIM:233400Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Perrault syndrome is a rare autosomal recessive disorder characterized by sensorineural hearing loss (SNHL) in both males and females, combined with ovarian dysgenesis (streak gonads) in affected females. The condition was first described by Maurice Perrault in 1951. Males with Perrault syndrome typically present with hearing loss alone, which can make diagnosis more challenging in the absence of affected female siblings. The hearing loss is bilateral and sensorineural, ranging from mild to profound, and may be present from birth or develop in early childhood. Affected females experience primary amenorrhea and infertility due to gonadal dysgenesis, with a 46,XX karyotype distinguishing the condition from Turner syndrome. Several genes have been identified as causative, including HSD17B4, HARS2, LARS2, CLPP, C10orf2 (TWNK), and ERAL1, all of which encode proteins involved in mitochondrial function or steroidogenesis. Some patients may develop additional neurological features, including progressive cerebellar ataxia, intellectual disability, and peripheral neuropathy, which has led to the distinction between Perrault syndrome type I (hearing loss and ovarian dysgenesis without neurological involvement) and type II (with neurological features). The neurological manifestations can be progressive and significantly impact quality of life. There is currently no cure or disease-modifying treatment for Perrault syndrome. Management is supportive and multidisciplinary, involving hearing aids or cochlear implants for hearing loss, hormone replacement therapy (estrogen and progesterone) for females with ovarian dysgenesis to induce secondary sexual characteristics and protect bone health, and neurological rehabilitation for those with cerebellar or peripheral nervous system involvement. Genetic counseling is recommended for affected families. Fertility is not achievable in affected females due to the absence of functional ovarian tissue, though options such as egg donation may be discussed.

Also known as:

Clinical phenotype terms— hover any for plain English:

Hypoplasia of the uterusHP:0000013Premature ovarian insufficiencyHP:0008209Streak ovaryHP:0010464Bicornuate uterusHP:0000813Secondary amenorrheaHP:0000869Disproportionate tall statureHP:0001519
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Perrault syndrome.

View clinical trials →

No actively recruiting trials found for Perrault syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Perrault syndrome community →

No specialists are currently listed for Perrault syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Perrault syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Perrault syndromeForum →

No community posts yet. Be the first to share your experience with Perrault syndrome.

Start the conversation →

Latest news about Perrault syndrome

No recent news articles for Perrault syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Perrault syndrome

What is Perrault syndrome?

Perrault syndrome is a rare autosomal recessive disorder characterized by sensorineural hearing loss (SNHL) in both males and females, combined with ovarian dysgenesis (streak gonads) in affected females. The condition was first described by Maurice Perrault in 1951. Males with Perrault syndrome typically present with hearing loss alone, which can make diagnosis more challenging in the absence of affected female siblings. The hearing loss is bilateral and sensorineural, ranging from mild to profound, and may be present from birth or develop in early childhood. Affected females experience prima

How is Perrault syndrome inherited?

Perrault syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.